BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 14, 2010
View Archived Issues
Novel extended-release, tamper-resistant formulation of oxycodone shows favorable PK
Read More
Merck KGaA identifiies novel oral heat shock protein 90 inhibitors for cancer
Read More
Novartis claims novel farnesyl pyrophosphate synthase inhibitors
Read More
Boehringer Ingelheim discloses novel 11beta-HSD1 inhibitors
Read More
UCB presents novel PI3K inhibitors
Read More
Novel KCNQ2/3 channel modulators claimed by Gruenenthal scientists
Read More
GlaxoSmithKline describes novel antibacterial agents
Read More
FDA requires more data before approving naproxcinod NDA for osteoarthritis
Read More
Viralytics set to meet with FDA to review proposed phase II melanoma study
Read More
Nymox reports safety monitoring committee update for phase III NX-1207 trials
Read More
Capstone Therapeutics continues second phase II AZX-100 trial
Read More
Resverlogix completes dosing in phase II ASSERT trial ahead of schedule
Read More
Soligenix completes enrollment in phase II trial of orBec in acute GVHD prevention
Read More
NexMed presents preclinical results for Vitaros in wound healing
Read More
Omeros selects clinical candidate for MASP-2 antibody program
Read More
PLx Pharma receives multiple grants from the NIH for developing safer NSAIDs
Read More
VGX-100 enhances antitumor effects of bevacizumab/docetaxel in vivo
Read More
Preclinical data support safety and potent antitumor activity of C-BiTE antibody
Read More
TransVax CMV vaccine safe and immunogenic up to 1 year in HSCT patients
Read More
Idenix Pharmaceuticals reports interim phase II and other data on anti-HCV treatments
Read More
Boston Scientific obtains E.U. approval for Taxus Element Stent System
Read More
Rabeprazole treatment beneficial in patients with functional dyspepsia
Read More
FDA approves IND application for AEZS-108 in bladder cancer
Read More
Pfizer to acquire Ergonex Pharma's investigational treatment for PAH
Read More
RegeneRx receives NIH grant for development of its heart attack drug RGN-352
Read More
GSK and Dong-A enter strategic alliance to copromote their products in South Korea
Read More